my brother in law is an ENT surgeon and to the docs the money is in selling the machines not doing the testing and Medicare has come down hard on rebates for testing - so for in Australia (I'm not speaking for overseas here) there seems to be little interest in ResApp. I love the disruption factor of RAP and Telehealth but as I said in my earlier post the repeated ballsing up of trials and results is : A a poor indicator for market reputation, and B has delayed a vital jump on getting into the market early. As said, I will listen for the ad on Macquarie tomorrow
Telehealth on the rise, page-552
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.001(1.82%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $240.9K | 4.194M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 361732 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 183839 | 1 |
View Market Depth
| Last trade - 14.08pm 22/04/2021 (20 minute delay) ? |
| RAP (ASX) Chart |
Day chart unavailable
